Анализ структуры и получение в прокариотической системе рекомбинантного белка G2 хантавируса серотипа пуумала, изолированного из зоонозного очага на территории Республики Башкортостан
Диссертация
Разработанные и лицензированные на сегодняшний день вакцинные препараты для профилактики ГЛПС представляют собой «живые» аттенюированные вакцины, созданные на основе вирусов серотипов HTN и SEU, циркулирующих, преимущественно, в странах Азии — Китае и Южной Корее (Song et al., 1998; Lee et al., 2001). К тому же, по ряду сообщений, указанные вакцинные препараты индуцируют низкий уровень синтеза… Читать ещё >
Содержание
- Список сокращений
- Глава 1. Обзор литературы
- 1. 1. Общие сведения о геморрагической лихорадке с почечным синдромом
- 1. 2. Молекулярная биология, филогения и зоогеография хантавирусов
- 1. 2. 1. Зоогеография хантавирусов
- 1. 2. 2. Особенности организации генома хантавирусов
- 1. 2. 3. Синтез вирусной РНК и созревание вирионов
- 1. 2. 4. Функции вирусных белков
- 1. 3. Вакцины
- 1. 3. 1. Генно-инженерные вакцины
- 1. 3. 2. ДНК-вакцины. Особенности генетической иммунизации
- 1. 3. 3. Преимущества ДНК-вакцин и возможные ограничения в их применении
- 1. 3. 4. Вакцины против геморрагической лихорадки с почечным синдромом
- 2. 1. Краткая характеристика объектов исследований
- 2. 2. Выделение и очистка тотальной РНК из образцов легочной ткани 54 рыжей uoRQBKii.(Clethrionomys glareolus)
- 2. 3. Выделение и очистка суммарной РНК из образцов крови 55 больных, заболевших ГЛПС
- 2. 4. Выделение и очистка плазмидной ДНК
- 2. 5. Выделение плазмидной ДНК методом мягкого лизиса
- 2. 6. Удаление РНК из препаратов плазмидной ДНК
- 2. 7. Расщепление ДНК рестрикционными эндонуклеазами
- 2. 8. Аналитический гель-электрофорез ДНК в неденатурирующих 60 условиях
- 2. 9. Препаративный гель-электрофорез ДНК в неденатурирующих 62 условиях
- 2. 10. Синтез кДЬЖ
- 2. 11. Полимеразная цепная реакция
- 2. 12. Элюция ДНК из агарозных гелей
- 2. 13. Концентрирование ДНК бутанолом
- 2. 14. Приготовление компетентных клеток
- 2. 15. Приготовление вектора для клонирования
- 2. 16. Секвенирование ДНК
- 2. 17. Цитирование вектора и фрагмента ДНК
- 2. 18. Трансформация компетентных клеток E. coli плазмидной ДНК
- 2. 19. Компьютерный анализ нуклеотидных последовательностей
- 2. 20. Индукция lac промотора
- 2. 21. Электрофорез полипептидов Е. col
- 2. 22. Твердофазный иммуноферментный анализ
- 2. 23. Реактивы и материалы
Список литературы
- Alexeyev О., Elgh F., Zhestkov A., Wadell G., Juto P. Hantaan and Puumala vitus antibodies in blood donors in Samara, an HFRS-endemic region in European Russia // Lancet. 1996. — V. 347. — P. 1483−1494.
- Alff P., Sen N., Gorbunova E., Gavrilovskaya I.N., Mackow E.R. The NY-1 Hantavirus Gn cytoplasmic tail coprecipitates TRAF3 and inhibits cellular interferon responses by disrupting TBK1-TRAF3 complex formation //J Virol. 2008. — V. 82.-P. 9115−9122
- Andersson H., Barth B.-U., Ekstrom M. Garoff H. Oligomerization-dependent folding of the membrane fusion protein of Semliki Forest virus. J. Virology. 1997. — V. 71. — P. 9654−9663.
- Antic D., Lim B.-U., Kang C.Y. Molecular characterization of the M genomic segment of the Seoul 80−39 virus-nucleotide and amino acid sequence comparisons with other hantaviruses reveal the evolutionary pathway // Virus Res. 1991. — V. 19. — P. 47−58.
- Antic D., Lim B.-U., Kang C.Y. Nucleotide seqvuence and coding capacity of the large (L) genomic RNA segment of Seoul 80−39 virus a mamber of the hantavirus genus // Virus Res. 1991. — V. 19. — P. 59−66.
- Antic D., Wright K.E., Kang C.Y. Maturation of Hantaan virus glicoprotein G1 and G2 // Virology. 1992. — V. 189. — P. 324−328.
- Antic D., Wright K.E., Kang C.Y. Maturation of Hantaan virus glycoproteins G1 and G2 // Virology.- 1992. V. 189. — P. 324−328.
- Antic D., Yong Kang C., Kristin S., Schamaljohn C., Vapalahti O., Vaheri A. Comparison of the deduced gene of the L, M, S genom segments of hantaviruses // Virus Res. 1992. — V. 24. — P. 35−46.
- Arikawa, J., Takashima, I., Hashimoto, N. Cell fusion by haemorrhagic fever with renal syndrome (HFRS) viruses and its application for titration of virus infectivity and neutralizing antibody // Arch Virology 1985. — V. 86. -P. 303−313.
- Avsic-Zupanc Т., Toney A., Anderson K., Chu Y.K., Schmaliohn C.S. (1995). Genetic and antigenetic properties of Dobrava virus: a unique member of the Hantavirus genus, family Bynyaviridae // J. Gen. Virol. -1995.-V. 76.-P. 2801−2808.
- Babiuk L.A., Lewis J., Suradhat S., Baca-Estrada M., Foldvari M., Babiuk S. Polynucleotide vaccines: potential for inducing immunity in animals // J. Biotechnol. 1999. — V. 73. — P. 131−140.
- Barry M., Johnston S. Biological features of genetic immunization // Vaccine. 1997. -V. 15. — P. 788−791.
- Beaty B. J., Miller B.R., Shope R.E., Rozhon E.J., Bishop D.H. Molecular basis of bunyavirus per os infection of mosquitoes: role of the middle-sized RNA segment // Proc. Natl. Acad. Sci. USA. 1982. — V. 79. — P. 12 951 297.
- Beaty B.J., Rozhon B.R., Gensemer P., Bishop D.H. Formation of reassortant buniaviruses in dually infected mosquitoes // Virology. 1981. -V.lll.-P. 662−665.
- Boshart M., Weber F., Jahn G., Dorsh-Hasler K., Fleckenstein В., Schaffner W. A very strong enhancer is located upstream of an immediate early gene of human cytomegalovirus. // Cell. 1985. — V. 44. — P.521−530.
- Bowen M.D., Kariwa H., Rollin P.E., Peters C.J., Nichol S.T. Genetic charaterization of a human isolate of Puumala hantavirus from France // Virus Res. 1995. — V. 38. — P. 279−89.
- Chapman B.S., Thayer R.M., Vincent K.A., Haigwood N.L. Effect of intron A from human cytomegalovirus immediate-early gene on heterologous expression in mammalian cells // Nuc. Acids Res. 1991. — V. 19. — P. 3979−3986.
- Chen S.-Y., Compans R.W. Oligomerization, transport, and Golgi retention of Punta Того virus glycoproteins // Virology. 1991. — V. 65. — P. 59 025 909.
- Chomczynski P., Sacchi N.// Anal. Biochem. 1987. -V. 162. -P.156−59.
- Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidium-thiocyanate-phenol-chlorofonn extraction // Anal. Biochem. — 1987.-V. 162.-P. 156−159.
- Chu Y.K., Jenning G., Leduc J.W., Lee H.W., Schmaliohn C.S., Dalrymple J.M. Serologgical relathionships among viruses in the Hantavirus genus, family Bunyaviridae // Virology. 1994. — V. 198. — P. 196−204.
- Clare J.J., Rayment F.B., Ballantine S.P., Sreekrismna K., Romanos M.A. High-level expression of tetanus toxin fragment С in Pichia pastoris strainscontaining multiple tandem integrations of the gene // BioTechnology. -1991.-V. 9.-P. 455−460.
- Collett M.S. Messenger RNA of the M segmeent RNA of Rift Vallay fever vurus//Virology.- 1986.-V. 151.-P. 151−156.
- Combet C., Blanchet C., Geourjon C., Deleage G. NPS network protein sequence analysis // Trends Biochem. Sci. 2000 — V. 25. — P. 147−150.
- Corver J., Ortiz A., Allison S.L., Schalich J., Heinz F.X., Wilschut, Membrane fusion activity of tick-borne encephalitis virus and recombinant subviral particles in a liposomal model system // Virology. 2000. — V. 269, 37−46.
- Davis H.L., Michel M.L., Whalen R.G. DNA-based immunization induces continuous secretion of hepatitis-B surface-antigen and high-levels of circulating antibody // Human Mol. Genet. 1993. — V. 2 — P. 1847−1851.
- Donelly J., Ulmer J., Shiver J., Margaret A. DNA vaccines // Annu. Rev. Immunol. 1997. — V. 15. — P. 617−648.
- Easterbrook J.D., Klein S.L. Immunological mechanisms mediating hantavirus persistence in rodent reservoirs // PLoS Pathog. -2008 V. 4. -P.42−49.
- Eisenberg D., Liithy R., Bowie J.U. VERIFY3D: assessment of protein models with three-dimensional profiles. Methods // Enzymol. 1997. — V. 277. — P. 396−404.
- Elliot R.M. Molecular biology of the Buniaviridae // J. Gen. Virol. 1990. -V. 71-P. 501−522.
- Epand R.M. Fusion peptides and the mechanism of viral fusion // Biochim. Biophys. Act.-2003.- V. 1614.-P. 116−121.
- Ferreira G., Monteiro G., Prazeres D., Cabral J. Downstream processing of plasmid DNA for gene therapy and DNA vaccine applications // Trends. Biotechnol. 2000. — V. 18. — P.380−388.
- Gallaher W.R., DiSimone M.J., Buchmeier M. J The viral transmemrane superfamily possible divergence of Arenavirus and Filovirus glycoproteins from a common RNA virus ancestor // Microbiol. -2001. — V. 1. — P.24—34
- Garcin D., Lezzi M., Dobbs M., Elliot R.M., Schmaljiohn C., Kang C.Y., Kolakofsky D. The 5'-ends of Hantaan virus (Buniaviridae) RNAs suggest a prime-and-realign mechanism for the initiation of RNA synthesis // J. Virol. 1995. — V. 69. — P. 5754−5762.
- Gibbons D.L., Vaney M.-C., Roussel A., Vigouroux A., Reilly В., Lepault, J., Kielian M., Rey F.A. Conformational change and protein-protein interactions of the fusion protein of Semliki Forest virus // Nature. 2004. -V. 427.-P. 320−325.
- Giulian G.G. Resolution of low molecular weight polypeptides in a non-urea sodium dodecyl sulfate slab polyacrylamid gel system // Fed. Proc. 1985. -V. 44.-P. 686−693.
- Gonzalez-Scarano F., Janssen R., Najar J.A., Pobjecky N., Nathanson N. An avirulent G1 glycoprotein variant of La Crosse bunyavirus with defective fusion function // J. Virol. 1985. — V. 54. — P. 757−763.
- Guirakhoo F., Heinz F.X., Mandl C.W., Holzmann H., Kunz C. Fusion activity of flaviviruses: comparison of mature and immature (prMcontaining) tick-borne encephalitis virions // J. Gen. Virol. 1991. — V. 72. -P. 1323−1329.
- Hacker J.K., Hardy J. L Adsorptive endocytosis of California encephalitis virus into mosquito and mammalian cells: a role for G1 // Virology. 1991. -V. 235.-P. 40−47.
- Hardestam J., Karlsson M., Falk K.I., Olsson G., Klingstrom J., Lundkvist A. Puumala hantavirus excretion kinetics in bank voles (Myodes glareolus) II Emerg. Infect. Dis. 2008 -V.14. — P. 1209−1215
- Henikoff S., Henikoff J.G. Protein family classification based on searching a database of blocks // Genomics. 1994. — V. 19. — P. 97−107.
- Hernandez L.D., Hoffman L.R., Wolfsberg T.G., White J.M. Virus-cell and cellcell fusion // Annu. Rev. Cell Dev. Biol. 1996. — V.12.- P. 627−661.
- Hjelle В., Chavez G., Torrez N., Yates S., Sarisky J., Webb J., Ascher M. Genetic identification of a novel hantavirus of the harvest mouse Reithrodontomys megalotis // J. Virol. 1994. — V. 68. — P. 6751−6754
- Holand J.J., Spindler K. Horodyski F. Rapid evolution of RNA genomes // Science. 1982 -V.215. — P.1577−1585.
- Hooper J., Kamrud K., Eigh F., Custer D., Schmaliohn C. DNA vaccination with Hantavirus M segment elicit neutralizing antibodies and protects against Seoul virus infection // Virology. 1999. — V. 255. — P.269−278.
- Huang H., Li X., Zehua Z. Genetic immunization with Hantavirus vaccine combining expression of G2 glycoprotein and fused interleukin-2 // Genetic Vaccines and Therapy. 2008. — v. 6. — P. 15−21.
- Ikegami Т., Won S., Peters C.J., Makino S. Characterization of Rift Valley Fever Virus Transcriptional Terminations // J. Virol. 2007 — V. 16 — P. 8421−8438.
- Janssen R ., Nathanson N., Endres M.J., Gonzalez-Scarano F. Virulence of La Crosse virus is under polygenic control // J. Virol. 1986. — V. 59. — P. 1−7.
- Jardetzky T.S., Lamb R.A. Structure of the parainfluenza virus 5 F protein in its metastable prefusion conformation // Nature 2004. — Vol. 438. — P. 3844.
- Jin M., Park J., Lee S. Hantaan virus enters cells by clathrindependent receptor-mediated endocytosis // J. Virol 2002. — V. 294. — P. 60−69.
- Kallio-Kokko, Leveelahti R. Human immune response to Puumala virus glycoproteins and nucleocapsid protein expressed in mammalian cells // Hannimari Journal of Medical Virology-2001. V. 65. — P. 605−613.
- Kamrud K., Hooper J., Eigh F., Schmaljohn C. Comparison of the protective of naked DNA, DNA-based Sindbis replicon, and packaged Sindbis replicon vectors expressing hantavirus structural genes in hamsters // Virology. -1999.-V. 263.-P. 209−219.
- Kim T.-Y., Choi Y., Cheong H.-S., Choe J. Identification of a cell surface 30 kDa protein as a candidate receptor for Hantaan virus // J. Gen. Virol. -2002.- V. 83.-P. 767−773.
- Krautkramer E., Zeier M. Hantavirus Causing Hemorrhagic Fever with Renal Syndrome Enters from the Apical Surface and Requires Decay-Accelerating Factor (DAF/CD55) // J. Virol. 2008 — V.82. — P. 4257−4264.
- Kyte J., Doolittle, R.F. A simple method for displaying the hydropathic character of a protein // J. Mol. Biol. 1982. — V. 157. — P. 105−132.
- Lai W.C., Bennett M., Johnston S.A., Barry M.A., Pakes S.P. Protection against Mycoplasma -pulmonis infection by genetic vaccination // DNA Cell Biol. 1995.-V. 14.-P. 643−651.
- Lee H.W., Baek L.J., Johnson K.M. Isolation of Hantaan virus, the etiologic agent of Korean hemorrhagic fever with renal syndrom in humans // Arch. Virol. Suppl. 1982. — V. 1. — P. 35−47.
- Lee H.W., Lee P.W. Korean hemorrhagic fever. I. Demonstration of causative antigen and antibodies // Korean J. of Internal Medicine. 1976. -V. 19.-P. 371−383.
- Lee P.W., Amyx H.L., Gajdusek D.C., Yanagihara R.T., Goldgaber D., Gibbs C.J. New hemorrhagic fever with renal syndrome-related virus in rodents in the United States // Lancet. 1982. — V. 2. — P. 1405−1411.
- Lee P.W., Gibbs С .J., Gajdusek D.C., Yanagihara R. Serotypic classification of hantaviruses by indirect immunofluorescent antibody and plaque reduction neutralization tests // J. Clin. Microbiol. 1985. — V. 22. -P. 940 944.
- Lescar J., Roussel A., Wien M.W., Navaza J., Fuller S.D., Wengler G., Wengler G., Rey F.A. The fusion glycoprotein shell of Semliki Forest virus: an icosahedral assembly primed for fusogenic activation at endosomal Ph // Cell -2001. V. 105.-P. 137−148.
- Lewis P.J., Cox G.J.M., Hurk S., Babiuk L. Polynucleotide vaccines in animals: enhancing and modulating responses // Vaccine. 1997. — V. 15. -P.861−864.
- Liang M., Li D., Xiao S.Y., Hang C., Rossi C.A., Schmaliohn C.S. Antigenic and molecular characterization of hantavirus isolates from China // Virus. Res. 1994. — V. 31. — P. 219−233.
- Lober C., Anheier В., Lindow S., Klenk H.-D., Feldmann H. The Hantaan virus glycoprotein precursor is cleaved at the conserved pentapeptide WAASA // Virology. 2001. — V. 289. — P. 224−229.
- Lorenz I.C., Allison S.L., Heinz F.X., Helenius A. Folding and dimerization of tickborne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum // J. Virol. 2002. — V. 76. — P. 5480−5491.
- Lundkvist A., Bjorsten S., Niklasson B. Immunoglobulin G subclass responses against the structural components of Puumala virus // J. Clin. Microbiol. 1993. -V. 31. — P. 368−372.
- Marquardt Т., Helenius A. Misfolding and agregation of newly synthesized proteins in the endoplasmic reticulum // J. Cell Biol. 1992. — V. 117. — P. 505−513.
- McAleer W.J., Buynak E.B., Maigetter R.Z., Wampler D.E., Miller W.J., Hilleman M.R. Human hepatitis В vaccine from recombinant yeast // Nature. -1984. V.307. — P. 178−180.
- McCaughey C., Shi X., Elliot R.M., Wyatt D.E., O’Neill H.J., Coyle P.V. Low pH-induced cytopathic effect a survey of seven hantavirus strains // J. Virol. Methods. — 1999.-V. 81.-P. 193−197.
- Mir A.M., Panganiban A.T. A protein that replaces the entire celluler elF4 °F complex //J.EMBO 2008. — P. 1 — 11
- Moreau P., Hen R., Wasylyr В., Everett R., Gaub M. P., Chambon P. The SV40 72 base pair repeat has a striking affect on gene expression both in SV40 and other chimeric recombinants // Nucl. Acids Res. 1981. — V. 9. -P. 6047−6068.
- Ogino M. Cell Fusion Activities of Hantaan Virus Envelope Glycoproteins // J. Virol. 2004. — Vol. 78. — P. 10 776−10 782.
- Parrington M.A., Lee P.-W., Kang C.Y. Molecular characterization of the Prospect Hill virus M RNA segment: a camparison with the M RNAsegment of other hantaviruses // J. of Gen. Virol. 1991. — V. 72. — P. 1845— 1854.
- Patterson J.L., Cabradilla C., Holloway B.P., Obueski J.F., Kolakofsky D. La Crosse virions contain a primer-stimulated RNA polymerase and a methylaited cap-dependent endonuclease // J. Virol. 1984. — V. 52. — P. 215−222.
- Pfarr D.S., Rieser L.A., Woychik R.P., Rottman F.M., Rosenberg M., Reff M.E. Differential effects of polyadenylation regions on gene expression in mammalian cells // DNA. 1986. — V.5. — P. 115−122.
- Philpott M., Hioe C., Sheerar M., Hinshaw V.S. Hemagglutinin mutations related to attenuation and altered cell tropism of a virulent avain influenza A virus // J. Virol. 1990. — V. 64. — P. 2941−2947.
- Pisetsky D.S. Immunostimulatory DNA: a clear and present danger // Nat. Med. 1997. — V. 3. — P. 829−831.
- Poch O., Sauvaget I., Delarue M., Tordo N. Identification of four conserved motif among the RNA-dependent polymerare encoding elements // J.Embo. 1989. — V. 8. — P. 3867−3879.
- Polo J.M., Belli B.A., Driver D.A., Frolov I., Sherrill S., Hariharan M.J. Stable alphaavirus packaging cell lines for Sindbis virus and Semliki Forest virus derived vectors // Prot. Natl. Acad. Sci.USA. — 1999. — V. 96. -P.4598−4603.
- Porter D.C., Wang J., Moldoveanu Z., McPherson S., Morrow C.D. Immunization of mice with poliovirus replicons expressing the C-fragment of tetatus toxin protects agains lethal challenge with tetanus toxin // Vaccine. 1997. — V. 15.-P. 257−264.
- Puthavathana P., Lee H.-W., Kang C.Y. Typing of Hantaviruses from five continents by polymerase chain reaction // Virus Res. -1992. -V.26. -P. 614.
- Raz E., Carson D.A., Parker S.E. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses //Proc. Natl. Acad. Sci. USA. 1994. -V. 91. — P. 9519−9523.
- Robinson H. Nucleic acid vaccines: an overiew // Vaccine. 1997. — V. 15. -P. 785−787.
- Rodriguez F., Whitton J. Enhancing DNA immunization // Virology. -2000. V. 268. — P. 233−238.
- Rouse B.T. Induction of mucosal immunity against herpes simplex virus by plasmid DNA immunization // J. Virol. 1997. — V.71. — P. 3138−3145.
- Rowe J.E., Jeor S.C., Riolo J., Otteson E.W., Monroe M.C., Henderson W.W., Ksiazek T.G., Rollin P.E., Nichol S.T. Coexistence of several novel hantaviruses in rodents indigenousto North America // Virology. 1995. -V. 213.-P. 122- 130.
- Sambrook J., Fritsch E.F., Maniatis T. // Molecular cloning: a laboratory manual./ 1989. p 134.
- Sanger F., Nicklen S., Coulson A.R. DNA sequencing with chain-terminating inhibitors // Proc. Natl. Acad. Sci. USA. 1977. — V.74. -P.5463−5467
- Sarzottii M., Dean T.A., Remington M.P., Ly C.D., Furth P.A., Robbins D.S. Induction of cytotoxic T cell responses in newborn mice by DNA immunization // Vaccine. 1997. — V. 15. — P. 795−797.
- Schmaliohn A.L., Li D.L., Negley D.L., Bressler D.S., Turell M.J., Korch G.W., Ascher M.S., Schmaliohn C.S. Isolation and initial characterization ofa newfound Hantavirus from California // Virology. 1995. — V. 206. — P. 963−972.
- Schmaliohn C., Chu Y., Schamaljohn A., Dalrymple J. Antigenic subunits of Hantaan virus expressed by baculovirus and vaccinia virus recombinants //J. Virol. 1990. -V. 64. -P. 3162−3170.
- Schmaliohn C.S., Jennings G.B., Hay J., Dalrymple J.M. Coding strategy of the S genome segment of Hantaan virus // Virology. 1986. — V. 155. -P. 633−643.
- Schmaliohn C.S., Schmaliohn A.L., Dalrymple J.M. Hantaan virus M RNA coding strategy nucleotide sequence and gene order // Virology. — 1987.-V. 157.-P. 31−39.
- Sealey P.G., Southern E.M. Gel electrophoresis of DNA // In: Gel Electrophoresis of Nucleic Acids. A practical approach. IRL Press, Oxford. -1982.-P. 39−76.
- Seder R. DNA-vaccines-designer vaccines for the 21st century // The New England J. of Medicine. 1999. — V. 341. — P. 277−278.
- Shope R.E., Rozhon E.J., Bishop D.H.L. Role of the middle-sized bunyavirus RNA segment in mouse virulence // Virology. 1981. — V. 174. -P. 79−86.
- Song G. Successful development of inactivated cell culture vaccine against HFRS in China // Proc. the fotht international conference on HFRS and Hantaviruses, USA. 1998. — P. 102−113
- Song J.W., Baek L.J., Nagle J.W., Schlitter D., Yanagihara R. Genetic and pathogenetic hantavirus from white-footed mouse (Peromyscus leucopus) latter //Lancet. 1996.- V. 344.-P. 1637−1648.
- Song J.-W., Kang H.J., Gu S.H., Moon S.S., Bennet S.N., Song K.-J., Baek L.J., Kim H.-C., Guinn M.L., Chong S.-T., Klein T.A., Yanagihara R. Characterization of Imjin Virus, a newly isolated hantavirus from the Ussuri
- White-Toothed Shrew (Crocidura lasiura) //j.Virol. 2009. — V.83. — P.6184−6191
- Spiropoulou C.F., Albarino C.G., Ksiazek T.G., Rollin P.E. Andes and Prospect Hill hantaviruses differ in early induction of interferon although both can down regulate interferon signaling // J. Virol. 2007 — V.81. — P. 2769−2776.
- Spiropoulou C.F., Morzunov S., Feldmann H., Sanchez A., Peters C.J., Nichol S.T. Genome structure and variability of a virus causing Hantavirus pulmonary syndrome // Virology. 1994. — V. 200. — P. 715−723.
- Stafford D.W., Bieber D. Concentration of DNA solutions by extraction with 2-butanol // Biochim. Biophys. Acta. 1975. — V.378. — P.18−21.
- Steege D.A. 5'- Terminal nucleotide sequence of Escherichia coli lactose repressor mRNA. Features of translational initiation and reinitiation sites // PNAS. 1977. -V. 74. — P. 4163−4167.
- Stohwasser R., Raab K., Darai G., Bautz E.K. Primary structure of the large (L) RNA segment of nephropathia epidemica virus strain Hallnas B1 coding for the viral RNA polymerase // Virology. 1991. — V. 183. — P. 386−391.
- Sundin D.R., Beaty B.J., Nathanson N., Gonzalez-Scarano F. A G1 glycoprotein epitope of La Crosse virus: a determinant of infection of Aedes triseriatus // Science. 1987. — V. 235. — P. 591−593.
- Tang D.C., Devit M., Jonston S.A. Genetic immunization is a simple method for eliciting an immune response // Nature. 1992. — V. 356. — P. 152−154.
- Taylor S., Frias-Staheli N., Garcia-Sastre A., Schmaljohn C. Hantaan virus nucleocapsid protein binds to importin a proteins and inhibits tumor necrosis factor alpha-induced activation of nuclear factor kappa В / J. Virol. 2009.- V. 83.-P. 1271−1279.
- Valenzuela P., Medina A., Rutter W., Ammerer G., Hall B. D. Synthesis and assembly of hepatitis В virus surface antigen particles in yeast // Nature.- 1982. V.298. — P. 347−350.
- Vapalahti O., Lundkvist A., Kallio-Kokko H., Paukku K., Julkunen I., Lankinen H., Vaneri A. Antigenic properties and diagnostic of Puumalavirus nucleocapsid protein expressed in insect cells // J. Clin. Microbiol. -1996.-V. 34.-P.l 19−125.
- Wells J.M., Wilson P.W., Norton P.M., Gasson M.J., Le Page R.W. Lactococcus lactis: High-level expression of tetanus toxin fragment С and protection against lethal challenge // Mol. Microbiol. 1993. — V.8. — P. 1155−1162.
- Wolff J.A., Malone R.W., Williams P. Direct gene transfer into mouse muscle in vivo // Sience. 1990. — V.247. — P. 1465−1468.
- Xiang Z.Q., Spitalnik S., Tran M., Wunner W.H., Cheng J., Ertl H. Vaccination with a plasmid vector carrieng the rabies virus glycoprotein gene induces protective immunity against rabies virus // Virology. 1994. — V. 139. — P.132−140.
- Xiao S.Y., Liang M., Schmaliohn C.S. Molecular and antigenic characterization of HV114, a hantavirus isolated from a patient with renal syndrom in China // J. Gen. Virol. 1993. — V. 74. — P. 1675−1679.
- Xiao S-Y., Ledus J.W., Chu Y.K., Schmaliohn C.S. Phylogenetic analyses of virus isolates in the genus Hantavirus, family Bunyaviridae // Virology. -1994.-V. 198.-P. 205−217.
- Yamasaki K., Weihl C., Roos R. Alternative translation initiation of Theiler’s murine encephalomyelitis virus // J. of Virol. -1999. V.73. -P.8519−8526.
- Yanigahara R., Svedmyr A.L., Lee P., Goldgaber D., Gajdusek D.-C., Gibbs Jr., Nystrom K. Isolation and propagation of nephropathia epidemica virus in bank voles // Scand. J.Infect. Dis. 1984. — V. 16. — P. 225−228.
- Yokoyama N., Maeda K., Mikami T. Recombinant viral vector vaccines for the veterinaiy use // J. Vet. Med. Sci. 1997. — V.59. — P.311−322.
- Yong-K.C., Gerald В., Jennings, Connie S., Schmaljohn A., Vaccinia Virus-Vectored Hantaan Virus Vaccine Protects Hamsters from Challenge with Hantaan and Seoul Viruses but Not Puumala Virus // Ft. Detrick, Frederick 21 702−50.
- Yoshimatsu K., Yoo Y., Yoshida R., Ishihara C., Azuma I., Arikawa J. Protective immunity of Hantaan virus nucleocapsid and envelope protein studies baculovirus expressed proteins // Arch. Virol. -1993. Vol. 130. — P.365−376.
- Гловер. Д. Новое в клонировании ДНК. Методы./ М. Мир, 1989. 346 с.
- Дебабов В.Г. ДНК-вакцинация и генотерапия на основе транзиентной экспрессии нуклеиновых кислот в соматических клетках человека и животных // Мол. Биол. 1997. — Т. 31. — С. 209−215.
- Дзагурова Т.К. и др., // Акт. пробл. вир. 1999. — Т.2. С.60
- Льюин. Гены. / М. Мир 1987. 544 с.
- Магазов Р.Ш., Кулагин В. Ф., Хайбуллина С. Ф. ГЛПС некоторые современные аспекты лечения и профилактики // Сборник статей «Геморрагическая лихорадка с почечным синдромом — пути решения проблемы». — Уфа. — 1995. — С. 5−9.
- Спасокукоцкий А. Генные вакцины. Актуальность разработки новых вакцин // Еженедельник Аптека. 2000. — № 229. — С. 1−7.
- Фазлыева P.M., Хунафина Д. Х., Камилов Ф.Х. Сборник статей
- Геморрагическая лихорадка с почечным синдромом в республике" Башкортостан. // Уфа. 1995. С. 243−250.
- Филдс Б. Н., Найп Д. М., Мэрфи Ф. А., Харрисон С., Уайли Д., Ройзман Б., Холланд Д. Дж., Рэмиг Р. Ф., Шоуп Р., Кауфман Р., Пенмен Ш., Грин М., Лоуи Д. Вирусология. М. / Мир. 1989.492 с.
- Якименко и др., Природно-очаговое заболевания человека // Сб. научных работ. 2001. — С.32−39.